The present invention relates to a pharmaceutical composition for inhibiting osteoclast differentiation and, more specifically, a composition for inhibiting osteoclast differentiation including 9-hydroxy-6,7-dimethoxydalbergiquinol as an active ingredient, which is used for developing medicine of bone disease and for preventing osteoporosis. In the present invention, provided are a pharmaceutical composition for preventing osteoporosis having 9-hydroxy-6,7-dimethoxydalbergiquinol and carriers pharmaceutically used.COPYRIGHT KIPO 2015본 발명은 파골세포 분화 억제를 위한 약학적 조성물에 관한 것이다. 더욱 구체적으로, 본 발명은 9-히드록시-6,7-디메톡시달베르기퀴놀을 유효성분으로 함유하는 파골세포 분화 억제를 위한 약학적 조성물에 관한 것으로 골 질환 치료제 개발과 골다공증 예방에 사용될 수 있다.
